A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

December 27, 2023

Study Completion Date

December 27, 2023

Conditions

Healthy

Interventions

DRUG

LY3541860

Administered either IV or SC.

DRUG

Placebo

Administered either IV or SC.

Trial Locations (1)

P-One Clinic, Hachiōji

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT05042310 - A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants | Biotech Hunter | Biotech Hunter